Matinas BioPharma Holdings (MTNB) Notes Payables (2015 - 2019)
Matinas BioPharma Holdings (MTNB) reported Notes Payables of $79937.0 for Q1 2019, up 87.83% year-over-year from $42559.0 in Q1 2018, and down 60.0% quarter-over-quarter from $199842.0 in Q4 2018.
Matinas BioPharma Holdings (MTNB) Notes Payables (2015 - 2019) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 5 years of Notes Payables data on file, last reported at $79937.0 in Q1 2019.
- Notes Payables for Q1 2019 came in at $79937.0, up 87.83% year-over-year; the trailing twelve-month figure through Mar 2019 was $79937.0 (up 87.83% YoY), and the FY2018 annual result was $199842.0, up 17.39% from the prior year.
- Notes Payables fell to $79937.0 in Q1 2019 per MTNB's latest filing, from $199842.0 in the prior quarter.
- Over five years, Notes Payables peaked at $319746.0 in Q3 2018 and troughed at $10000.0 in Q1 2015.
- A 5-year average of $124530.8 and a median of $98991.5 in 2016 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2016 and 2018: Notes Payables soared 1788.73% in 2016, then dropped 9.87% in 2018.
- A 5-year view of Notes Payables shows it stood at $10000.0 in 2015, then surged by 1080.46% to $118046.0 in 2016, then soared by 44.21% to $170236.0 in 2017, then rose by 17.39% to $199842.0 in 2018, then sank by 60.0% to $79937.0 in 2019.
- Business Quant data shows MTNB's Notes Payables at $79937.0 in Q1 2019, $199842.0 in Q4 2018, and $319746.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 79,937.00 |
| Dec 31, 2018 | 199,842.00 |
| Sep 30, 2018 | 319,746.00 |
| Mar 31, 2018 | 42,559.00 |
| Dec 31, 2017 | 170,236.00 |
| Sep 30, 2017 | 297,912.00 |
| Mar 31, 2017 | 47,218.00 |
| Dec 31, 2016 | 118,046.00 |
| Sep 30, 2016 | 188,873.00 |
| Sep 30, 2015 | 10,000.00 |
| Jun 30, 2015 | 10,000.00 |
| Mar 31, 2015 | 10,000.00 |